Sign up to save your podcasts
Or
Share The TUXEDO-2 Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The TUXEDO-2 Trial
Sripal Bangalore and C. Michael Gibson discuss whether ticagrelor is noninferior to prasugrel in patients with diabetes and multivessel CAD undergoing PCI.
View all episodes
By TCTMD
4
22 ratings
Sripal Bangalore and C. Michael Gibson discuss whether ticagrelor is noninferior to prasugrel in patients with diabetes and multivessel CAD undergoing PCI.
More shows like Talking Points
View all
NEJM This Week
324 Listeners
JAMA Clinical Reviews
500 Listeners
JACC This Week
167 Listeners
This Week in Cardiology
903 Listeners
Heart Sounds Podcast
12 Listeners
The Curbsiders Internal Medicine Podcast
3,376 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
137 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
731 Listeners
Annals On Call Podcast
197 Listeners
JAMA Medical News
90 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Cardionerds: A Cardiology Podcast
435 Listeners
Critical Care Time
273 Listeners